Mumbai eye doctor, Lalbaug

Mumbai eye doctor, Lalbaug

 

We shall discuss three questions here:

1. OT fumigation in Indian setting

2. Intra cameral antibiotics as prophylaxis for endophthalmitis

3. Intra ocular surgery in pathological myopic eyes

 

1. As we know formalin used for fumigation of OT is carcinogenic so what is good & economical alternative for fumigation. Also from whom (manufacturer details) it can be made available. What machine to be used with it? (same as fumigation machine or different). And also safety guidelines as far as this new agent is used.

Responses:

No. 1

In Pune Lemongaurd is available , add Incidure to Mop your OT with AC on.2-3 hrs before surgery if Moping done acts for 3-5 hours according to movement in & out of OT I use the same for last more than 15 years since I stopped Formalin.

No: 2

Bacillocid, Mfg Raman & Weil, Mumbai

For OT sterilization Mix one cap full in 1 Ltr water and spray with the spraying manual unit supplied by the company like normal  scent or deo spray on your table and other theatre equipment Safe and effective

 

2. What is the technique of using intra-cameral moxifloxacin in cataract surgery? Do we fill the chamber and leave it there? Or do we wash it out? If so, after how long? One company markets 0.5ml ‘Unims’ of Moxifloxacin. Can they be used directly? Do please share your experience.

Responses:

No. 1

All doctors are using 0.1 ml or less after conclusion of surgery and injecting into the anterior chamber with a tuberculin syringe and a cannula. Most common dose is 0.06 ml of  undiluted moxifloxacin.  It can be left there. no need to wash it out. It is not toxic to the intra ocular tissues. Most internet discussions state that vigamox is used for this purpose. Some are using one vial per patient and others are drawing many  doses from a single vial and using it for that days list. One bottle per theatre day. Cochrane Summary advises intracameral antibiotic to reduce endophthalmitis. A paper from LVP also advises the same. In general without intracameral antibiotics the endoph rate is around 1 in 1000 to 1 in 1300. With intra cameral moxi the endop rate is 1 in 3000 to 1 in 5000 cataract surgeries. Moxi will reduce isolated endop and will not reduce cluster endop.  Standard precautions are always followed.

No: 2

You can use Unims 0.5ml with added 0.5ml of RL Works wonderfully. See that you remove all the viscoelastics from bag also from back of IOL.

No: 3

I have been now using Intra Cameral Moxifloxacin for close to 3 years. I have only tried Vigamox as a Brand. I have not found any Anterior Chamber reation attributable to Intra-cameral Moxifloxacin. After completing the Cataract Surgery I use the sideport to inject 0.1 ml of moxifloxacin in the Anterior chamber. I dont wash it off.

It has worked for me well.

No: 4

“I am aware of the particular case regarding endothelial toxicity following the use of 4 Quin Prefilled. The surgeon who has referred the case to Dr. Abishek Saraf has in fact accepted that he injected a much larger volume of moxifloxacin 0.5% (over 0.5ml). This is what may have contributed to the occurence of endothelial damage. Literature reports, practice opnions and the marketing company has always advised that no more than 0.1ml of 0.5% moxifloxacin solution should be administered for safe prophylaxis of post operative endophthalmitis. It is important to convey this correct dose to surgeons else risk of TASS will always be a concern.”

 

3. Since we are in the
era of refractive surgery for high myopes in the form of
ICL, i would like to know your comments about the role of
clear lens extraction in high myopes in present day
scenario.i recently came across a young boy with bilateral
Rd following clear lens extraction as the operating surgeon
had assured the patient that he would be relieved of his
glasses.but unfortunately he ended with a bilateral
pseudophakic RD

Responses:
No: 1

Patients
do develop RD post ICL, that too with in a matter or hours
or days. This has been reported and we have see a couple of
patients such as this as well. Difficult to decide which is
the lesser evil to pass a judgement.

No: 2

As we all know clear lens extraction has a role
in reducing refractive power in Myopics. Same goes with
ICL too. But in myopics I personally feel that we should go
with other modalities like glasses, contact lenses or even
lasik (if fundus has no pathological myopia change).

Invasive procedures like clear lens extraction or ICL can
lead to more dreaded complications as you have already
mentioned.
Let it be more simple, safe and fruitful

No: 3

In eyes with “PATHOLOGICAL” myopia, the risk is there with any kind of intraocular intervention. Even I have seen patients who were operated filtering surgery(trab) for preventing progression of myopia ended up in RD within few weeks. These eyes are as such prone to development of RD and any kind of intraocular intervention can “PRECIPITATE” the eventuality. So the safer alternatives are non-invasive measures like spectacles and contact lenses. If one wants to know relative risk of each procedure, we need to have a trial comparing all invasive procedures. There is enough evidence in literature that “non-invasive” approach is much better than “invasive” approach in these eyes.

If we want to talk in terms of “I have not seen in so many cases that I have done”, I prefer to quote one example:
There used to be a time when all exclusive scleral buckling procedures were being performed with diathermy for retinopexy and the success rate in supposedly best hands was 75% only. Then came, cryopexy which changed the success rate to almost 99%. Now, no one uses diathermy for retinopexy!! The surgeon who got success with diathermy in 49 out of 50 cases could not claim that it is the successful procedure as most of the peers could not get same results.

One more procedure was RK which could not stand the test of time. All of us know how much hype was there behind it and how it faded within few years. There are few surgeons who still continue doing it!

LASIK stayed back as the selection criteria were made strict from beginning of its era. If someone does ICL for a “NON-pathological” high myopia, the risk of any intraocular event may be similar to that after LASIK. And the same procedure if done for pathological high myopia, it will definitely carry higher risk for RD (LASIK is not recommended for these eyes anyway!!). Clear lens extraction (without any complication) with IOL (it is recommended to put IOL even if it is of zero power to reduce eventualities), according to me carries the same risk as that of ICL for RD as the “intraocular manipulation” is almost equal with both procedures.

These “pathological” high myopia cases need not have any treatable lesion(like lattice) for development of RD. The word “pathological” itself signifies the risk. There may be zonular dehisence, entire vitreous may be pathological with unpredectable strong adherence to retina at many places. These eyes end up in RD when PVD gets induced with any intraocular manipulation (even a intravitreal anti-VEGF injection for myopic CNVM can result in RD- I saw a case). As we discussed many times before, the results of surgery for RD in these pathological eyes are much worse than in other eyes with RD.

I agree with Dr. Kaushik that there should be clear counselling before contemplating any procedure. During counselling, the gravity of a situation of having a serious complication should also be impressed upon the patient. This part of counselling should be given equal importance to the “marketing” part…..

 

borders

 

At Borders in Santa Clarita, CA on May 17, 2010. The Borders went defunct on Feb 16, 2011 when the company announced that it had filed for Chapter 11 bankruptcy protection, listing $1.275 billion in assets and $1.293 billion in debts in its filing.

santa clarita to LA

Driving from Santa Clarita to LA on I-5 South

I-5 North 7 am

 

Driving to LA from Orange County.  This is the crazy rush hour traffic on I-5 North at 7.00 AM.

Dr. Navin Kumar Gupta
http://shankarnetrika.com

Director, Shankar Netrika Medical Retina Specialist Retina Fellow, University of California, Irvine, USA (2008-2010) Research Fellow, Johns Hopkins Hospital, Baltimore, USA (2007-2008) Anterior Segment Fellow, Aravind Eye Hospital, Madurai (2004-2006) Affiliate of SEE International, Santa Barbara, USA Collaborator and Advisor of Phaco Training Program, Anjali Eye Center

×

Hello!

Click one of our contacts below to chat on WhatsApp

×